Literature DB >> 1663733

In vitro antiviral activity of polyoxotungstate (PM-19) and other polyoxometalates against herpes simplex virus.

M Fukuma1, Y Seto, T Yamase.   

Abstract

Polyoxotungstates with Keggin-type structure were found to demonstrate marked antiherpetic activity. K7[TiW10PO40].6H2O (PM-19) caused a decrease in plaque formation by several strains of herpes simplex virus (HSV) type 1, including acyclovir-resistant (thymidine kinase-negative) strains, at concentrations which were not toxic to the host cells. The 50% plaque-inhibiting concentration (EC50) for the different strains was between 20 and 50 micrograms/ml. Single-cycle HSV growth was also inhibited by PM-19. PM-19 inhibited viral DNA synthesis in HSV-infected cells at a concentration of 5 micrograms/ml but did not exhibit a virucidal effect, and pretreatment of the host cells with PM-19 did not provide resistance to herpes infection. Yet, virus adsorption to the cells was markedly affected at PM-19 concentrations higher than 25 micrograms/ml. PM-19 was also effective against human cytomegalovirus, but not against adenoviruses and varicella-zoster virus, although it did delay the development of the cytopathic effect of these viruses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663733     DOI: 10.1016/0166-3542(91)90047-u

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  9 in total

1.  Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain.

Authors:  Hermann Bultmann; Jeremy Teuton; Curtis R Brandt
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

Review 2.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

3.  The elements of life and medicines.

Authors:  Prinessa Chellan; Peter J Sadler
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2015-03-13       Impact factor: 4.226

4.  Can polyoxometalates (POMs) prevent of coronavirus 2019-nCoV cell entry? Interaction of POMs with TMPRSS2 and spike receptor domain complexed with ACE2 (ACE2-RBD): Virtual screening approaches.

Authors:  Nahid Shahabadi; Mohammad Mahdavi; Saba Zendehcheshm
Journal:  Inform Med Unlocked       Date:  2022-03-05

5.  New composition of tungsten has a broad range of antiviral activity.

Authors:  Hranush Avagyan; Anaida Mirzoyan; Ferdinand Mirzoyan; Roza Izmailyan; Sona Hakobyan; Henry Voskanyan; Zara Semerjyan; Aida Avetisyan; Hranush Arzumanyan; Elena Karalova; Liana Abroyan; Lina Hakobyan; Nane Bayramyan; Nazeli Gevorgyan; Alexander Karalyan; Zaven Karalyan
Journal:  Antivir Chem Chemother       Date:  2022 Jan-Dec

Review 6.  Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease.

Authors:  Xuechen Wang; Shengnan Wei; Chao Zhao; Xin Li; Jin Jin; Xuening Shi; Zhenyue Su; Juan Li; Juan Wang
Journal:  J Biol Inorg Chem       Date:  2022-06-17       Impact factor: 3.862

7.  Molecular simulation study of the binding mechanism of [α-PTi2W10O40]7- for its promising broad-spectrum inhibitory activity to FluV-A neuraminidase.

Authors:  JianPing Wang; DongHua Hu; ZhongMin Su
Journal:  Chin Sci Bull       Date:  2010-08-14

Review 8.  Polyoxometalates active against tumors, viruses, and bacteria.

Authors:  Toshihiro Yamase
Journal:  Prog Mol Subcell Biol       Date:  2013

9.  Increased in vitro Anti-HIV Activity of Caffeinium-Functionalized Polyoxometalates.

Authors:  Ana G Enderle; Matteo Bosso; Rüdiger Groß; Magdalena Heiland; Mariela Bollini; María J Culzoni; Frank Kirchhoff; Jan Münch; Carsten Streb
Journal:  ChemMedChem       Date:  2021-05-26       Impact factor: 3.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.